In addition, our results are consistent with the previous report showing that PD‐1 high TIL, with a unique expression pattern of CXCL13, predicts favorable outcomes of PD‐1 blockade in an NSCLC cohort.18 The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.